These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27919492)

  • 1. Corrigendum to 'Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature' [Mult. Scler. Relat. Disord. 9 (2016) 158-162].
    Grebenciucova E; Reder AT; Bernard JT
    Mult Scler Relat Disord; 2016 Nov; 10():213. PubMed ID: 27919492
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to: "A case of Takotsubo syndrome during a multiple sclerosis brainstem relapse" [Mult. Scler. Relat. Disord. 24 (2018) 1-2].
    Prestipino E; Squitieri M; Razzolini L; Pastò L; Forleo P; Amato MP
    Mult Scler Relat Disord; 2019 May; 30():292. PubMed ID: 30987753
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "Sexual dysfunction in patients with multiple sclerosis" [Mult. Scler. Relat. Disord. 2 (2) (2013) 117-123].
    Orasanu B; Frasure H; Wyman A; Mahajan ST
    Mult Scler Relat Disord; 2013 Jul; 2(3):259. PubMed ID: 25877734
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis" [Mult. Scler. Relat. Disord. 4 (2015) 104-111].
    Racosta JM; Sposato LA; Morrow SA; Cipriano L; Kimpinski K; Kremenchutzky M
    Mult Scler Relat Disord; 2015 Jul; 4(4):385. PubMed ID: 26195062
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Editors' Welcome" [Mult. Scler. Relat. Disord., 29 (2019) A1-A2].
    Levy PM
    Mult Scler Relat Disord; 2019 Jul; 32():138. PubMed ID: 31229185
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to: Comment on Y.D. Fragoso et al.: "Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod" [Mult. Scler. Relat. Disord. (2017)].
    Fragoso YD; Spelman T; Boz C; Alroughani R; Lugaresi A; Vucic S; Butzkueven H; Terzi M; Havrdova E; Horakova D; Granella F; Olascoaga J; Menoyo JLS; Pucci E; Barnett M; Brooks JBB; Haartsen J;
    Mult Scler Relat Disord; 2018 May; 22():166. PubMed ID: 29807821
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.
    Grebenciucova E; Reder AT; Bernard JT
    Mult Scler Relat Disord; 2016 Sep; 9():158-62. PubMed ID: 27645366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice[Mult Scler Relat Disord. 2020 Oct;45:102428].
    Carnero Contentti E; Rojas JI; Cristiano E; Daccach Marques V; Flores-Rivera J; Lana-Peixoto M; Carlos N; Papais-Alvarenga R; Sato DK; Soto de Castillo I; Correale J
    Mult Scler Relat Disord; 2021 Jul; 52():103026. PubMed ID: 34044260
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Does Natalizumab treatment increase the risk of herpes simplex encephalitis in multiple sclerosis? Case and discussion" [Multiple Scler. Relat. Disord. 2 (4) (2013) 385-387].
    Sharma K; Ballham SA; Inglis KE; Renowden S; Cottrell DA
    Mult Scler Relat Disord; 2014 Jan; 3(1):136-7. PubMed ID: 25877985
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment on "Fingolimod effects on left ventricular function in multiple sclerosis" Mult Scler 2015.
    Bakshi R; Häring DA
    Mult Scler; 2016 Apr; 22(5):707-8. PubMed ID: 26359277
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum.
    Mult Scler; 2017 Dec; 23(14):NP1. PubMed ID: 28956510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum.
    Mult Scler; 2016 Oct; 22(11):NP1. PubMed ID: 27698283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum.
    Mult Scler; 2014 May; 20(6):768. PubMed ID: 28072565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum.
    Mult Scler; 2016 Oct; 22(12):NP8. PubMed ID: 27578773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum.
    Mult Scler; 2017 Jan; 23(1):NP1. PubMed ID: 27888256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to "Impaired eye blink classical conditioning distinguishes dystonic patients with and without tremor" [Park. Relat. Disord. 31 (2016) 23-27].
    Antelmi E; Di Stasio F; Rocchi L; Erro R; Liguori R; Ganos C; Brugger F; Teo J; Berardelli A; Rothwell J; Bhatia KP
    Parkinsonism Relat Disord; 2017 Feb; 35():102. PubMed ID: 27989567
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's disease" [Parkinsonism Relat. Disord. 25C (2016) 58-64].
    Martinez-Horta S; Perez-Perez J; van Duijn E; Fernandez-Bobadilla R; Carceller M; Pagonabarraga J; Pascual-Sedano B; Campolongo A; Ruiz-Idiago J; Sampedro F; Landwehrmeyer GB; ; Kulisevsky J
    Parkinsonism Relat Disord; 2016 Oct; 31():161. PubMed ID: 27567724
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum.
    Mult Scler; 2016 Dec; 22(14):NP13. PubMed ID: 27754942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum.
    Mult Scler; 2018 Sep; 24(10):1390. PubMed ID: 29992853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum to "Determinants of denervation-independent depletion of putamen dopamine in Parkinson's disease and multiple system atrophy" [Parkinsonism Relat. Disord. 35 (2017) 88-91].
    Goldstein DS; Sullivan P; Holmes C; Mash DC; Kopin IJ; Sharabi Y
    Parkinsonism Relat Disord; 2017 Jun; 39():95. PubMed ID: 28392299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.